Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, Joseph W. Fay et al.|Journal of Clinical Oncology|2013Cited by 439
Non-Hodgkin’s LymphomasAndrew D. Zelenetz, Furhan Yunus, Jeremy S. Abramson et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 329
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016Steven M. Horwitz, Pierluigi Porcu, Andrew D. Zelenetz et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 141
Diffuse Large B-Cell Lymphoma Version 1.2016Andrew D. Zelenetz, Hema Sundar, Leo I. Gordon et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 87
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017William G. Wierda, Hema Sundar, Andrew D. Zelenetz et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 62